A petition presented to the Supreme Court on May 1, 2024, requests the formation of a medical panel to assess the safety risks associated with the Covishield vaccine. Advocating for an expert-led examination, the plea highlights concerns over increased instances of heart attacks and sudden collapses post-vaccination, referencing revelations made in a UK court document by AstraZeneca, the vaccine’s developer. Acknowledging AstraZeneca’s disclosure of a potential link between Covishield and Thrombosis with Thrombocytopenia Syndrome (TTS), the petition emphasizes the need for thorough investigation. Additionally, the plea urges the establishment of a ‘Vaccine Damage Payment System’ for affected citizens and families, along with stringent measures to combat the circulation of counterfeit vaccines.
Supreme Court Petition Seeks Expert Panel to Evaluate Covishield Safety Concerns
![](https://affairsace-media.s3.ap-south-1.amazonaws.com/2024/05/02094947/covishield-vaccine-05-860x484.jpg)